Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

• Status: Active, not recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Colorado Joint Replacement
• Treatments: Benzoyl Peroxide

Criteria

Inclusion Criteria:

• Patients who are 18 to 79 85 years of age

• CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital

• CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.

• CJR patients without a previous arthroplasty procedure who have established care with our practice.

Exclusion Criteria:

• Previous history of hip infection

• Current antibiotic use or antibiotic use within the past week

• Previous history of Cutibacterium joint infection

• Current immunodeficiency disease or disorder

• Patients with active psoriatic disease or other focal inflammation over the hip

• Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)